Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WHAMM pseudogene 1 (WHAMMP1) is a processed pseudogene on human chromosome 15, derived from the protein-coding gene WHAMM. WHAMMP1 itself does not encode a functional protein and is not known to be expressed at the protein level. No direct biological function or disease role has been established. WHAMM, the parent gene, is involved in actin nucleation, Golgi membrane association, and microtubule binding, but these functions do not extend to WHAMMP1[4][3][5]. **Note: If you are seeking pharmacologically relevant targets, focus on the parent gene (WHAMM) rather than this pseudogene.**
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WHAMM pseudogene 1 (WHAMMP1).